8-K - Aspire Biopharma Holdings, Inc. | StockGist

Current Report Details

Event Type

Management Change

Disclosure

Mandatory

Variant

8-K

Items Reported

5.02

. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January

Management Change

Company, the Board of Directors, or any member of the Company

Exhibits (1)

8-K